Literature DB >> 11204436

Indapamide, a thiazide-like diuretic, decreases bone resorption in vitro.

A Lalande1, S Roux, M A Denne, E R Stanley, P Schiavi, D Guez, M C De Vernejoul.   

Abstract

We recently showed that indapamide (IDP), a thiazide-related diuretic, increases bone mass and decreases bone resorption in spontaneously hypertensive rats supplemented with sodium. In the present study, we evaluated the in vitro effects of this diuretic on bone cells, as well as those of hydrochlorothiazide (HCTZ), the reference thiazide, and acetazolamide (AZ), a carbonic anhydrase (CA) inhibitor. We showed that 10(-4) M IDP and 10(-4) M AZ, as well as 10(-5) M pamidronate (APD), decreased bone resorption in organ cultures and in cocultures of osteoblast-like cells and bone marrow cells in the presence of 10(-8) M 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. We investigated the mechanism of this antiresorptive effect of IDP; IDP decreased osteoclast differentiation as the number of osteoclasts developing in coculture of marrow and osteoblast-like cells was decreased markedly. We then investigated whether IDP affected osteoblast-like cells because these cells are involved in the osteoclast differentiation. Indeed, IDP increased osteoblast-like cell proliferation and alkaline phosphatase (ALP) expression. Nevertheless, it did not modify the colony-stimulating factor 1 (CSF-1) production by these cells. In addition, osteoblast-like cells expressed the Na+/Cl- cotransporter that is necessary for the renal action of thiazide diuretics, but IDP inhibited bone resorption in mice lacking this cotransporter, so the inhibition of bone resorption and osteoclast differentiation did not involve this pathway. Thus, we hypothesized that IDP may act directly on cells of the osteoclast lineage. We observed that resorption pits produced by spleen cells cultured in the presence of soluble osteoclast differentiation factor (sODF) and CSF-1 were decreased by 10(-4) M IDP as well as 10(-5) M APD. In conclusion, in vitro IDP increased osteoblast proliferation and decreased bone resorption at least in part by decreasing osteoclast differentiation via a direct effect on hematopoietic precursors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204436     DOI: 10.1359/jbmr.2001.16.2.361

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

Review 1.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

2.  Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial.

Authors:  Karen L Margolis; Lisa Palermo; Eric Vittinghoff; Gregory W Evans; Hal H Atkinson; Bruce P Hamilton; Robert G Josse; Patrick J O'Connor; Debra L Simmons; Margaret Tiktin; Ann V Schwartz
Journal:  J Gen Intern Med       Date:  2014-08-16       Impact factor: 5.128

3.  Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria.

Authors:  Víctor García-Nieto; Margarita Monge-Zamorano; Montserrat González-García; María Isabel Luis-Yanes
Journal:  Pediatr Nephrol       Date:  2011-08-28       Impact factor: 3.714

Review 4.  Nephrolithiasis-associated bone disease: pathogenesis and treatment options.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Rajiv Kumar; Andreas Pasch; Orson W Moe
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

5.  The relation between bone and stone formation.

Authors:  Nancy S Krieger; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2012-12-18       Impact factor: 4.333

Review 6.  Understanding and targeting osteoclastic activity in prostate cancer bone metastases.

Authors:  J L Sottnik; E T Keller
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

Review 7.  Delapril plus indapamide: a review of the combination in the treatment of hypertension.

Authors:  Luca Cavalieri; Giovanni Cremonesi
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

8.  Fracture risk and the use of a diuretic (indapamide SR) +/- perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET).

Authors:  Christopher J Bulpitt; Ruth Peters; Jan A Staessen; Lutgarde Thijs; Marie-Christine De Vernejoul; Astrid E Fletcher; Nigel S Beckett
Journal:  Trials       Date:  2006-12-19       Impact factor: 2.279

9.  Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone.

Authors:  Melita M Dvorak; Cyrille De Joussineau; D Howard Carter; Trairak Pisitkun; Mark A Knepper; Gerardo Gamba; Paul J Kemp; Daniela Riccardi
Journal:  J Am Soc Nephrol       Date:  2007-07-26       Impact factor: 10.121

10.  The effects of antihypertensive drugs on bone mineral density in ovariectomized mice.

Authors:  Kwi Young Kang; Yoongoo Kang; Mirinae Kim; Youngkyun Kim; Hyoju Yi; Juryun Kim; Hae-Rin Jung; Sung-Hwan Park; Ho-Youn Kim; Ji Hyeon Ju; Yeon Sik Hong
Journal:  J Korean Med Sci       Date:  2013-07-31       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.